Literature DB >> 18472152

Adenosine induces airway hyperresponsiveness through activation of A3 receptors on mast cells.

Xiaoyang Hua1, Kelly D Chason, Bertil B Fredholm, Deepak A Deshpande, Raymond B Penn, Stephen L Tilley.   

Abstract

BACKGROUND: The mechanisms responsible for the development of airway hyperresponsiveness in asthma are poorly understood. Adenosine levels are high in the lungs of patients with asthma, but a role for adenosine in the development of this cardinal feature of asthma has not been previously reported.
OBJECTIVE: To determine the capacity of adenosine to induce airway hyperresponsiveness, and to investigate the mechanisms behind these effects of adenosine on airway physiology.
METHODS: Wild-type C57BL/6 mice were exposed to aerosolized adenosine analog adenosine-5' N-ethylcarboxamide (NECA), and subsequent hyperresponsiveness to methacholine was investigated by measuring airway mechanics after anesthesia and tracheostomy. Similar experiments were conducted with A(1)-deficient, A(3)-deficient, and mast cell-deficient mice, as well as with mast cell-deficient mice engrafted with wild-type (wt) or A(3)(-/-) mast cells. The effect of NECA on methacholine-induced tension development in ex vivo tracheal rings was also examined.
RESULTS: Exposure of wt mice to NECA resulted in the robust induction of airway hyperresponsiveness. NECA failed to induce hyperresponsiveness to methacholine in tracheal ring preps ex vivo, and NECA-induced airway hyperresponsiveness in vivo was not affected by the genetic inactivation of the A(1) adenosine receptor. In contrast, NECA-induced airway hyperresponsiveness was abolished in A(3) adenosine receptor-deficient mice and in mice deficient in mast cells. Reconstitution of mast cell-deficient mice with wt mast cells restored hyperresponsiveness, whereas reconstitution with A(3) receptor-deficient mast cells did not.
CONCLUSION: Adenosine induces airway hyperresponsiveness indirectly by activating A(3) receptors on mast cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18472152      PMCID: PMC4439463          DOI: 10.1016/j.jaci.2008.03.026

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  45 in total

1.  ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors.

Authors:  Yu Chen; Ross Corriden; Yoshiaki Inoue; Linda Yip; Naoyuki Hashiguchi; Annelies Zinkernagel; Victor Nizet; Paul A Insel; Wolfgang G Junger
Journal:  Science       Date:  2006-12-15       Impact factor: 47.728

2.  Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics.

Authors:  S Ying; M Humbert; J Barkans; C J Corrigan; R Pfister; G Menz; M Larché; D S Robinson; S R Durham; A B Kay
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

3.  Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells.

Authors:  C A Salvatore; S L Tilley; A M Latour; D S Fletcher; B H Koller; M A Jacobson
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

Review 4.  Sense and antisense: therapeutic potential of oligonucleotides and interference RNA in asthma and allergic disorders.

Authors:  Howard A Ball; Michael R Van Scott; Cynthia B Robinson
Journal:  Clin Rev Allergy Immunol       Date:  2004-12       Impact factor: 8.667

5.  Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5'-monophosphate.

Authors:  G D Phillips; V L Scott; R Richards; S T Holgate
Journal:  Eur Respir J       Date:  1989-03       Impact factor: 16.671

6.  A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice.

Authors:  Hays W J Young; Jose G Molina; Dawn Dimina; Hongyan Zhong; Marlene Jacobson; Lee-Nien L Chan; Teh-Sheng Chan; James J Lee; Michael R Blackburn
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

7.  Evidence of a role of tumor necrosis factor alpha in refractory asthma.

Authors:  Mike A Berry; Beverley Hargadon; Maria Shelley; Debbie Parker; Dominick E Shaw; Ruth H Green; Peter Bradding; Christopher E Brightling; Andrew J Wardlaw; Ian D Pavord
Journal:  N Engl J Med       Date:  2006-02-16       Impact factor: 91.245

8.  Stimulation of adenosine A1 receptors and bradykinin receptors, which act via different G proteins, synergistically raises inositol 1,4,5-trisphosphate and intracellular free calcium in DDT1 MF-2 smooth muscle cells.

Authors:  P Gerwins; B B Fredholm
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Involvement of A1 adenosine receptors and neural pathways in adenosine-induced bronchoconstriction in mice.

Authors:  Xiaoyang Hua; Christopher J Erikson; Kelly D Chason; Craig N Rosebrock; Deepak A Deshpande; Raymond B Penn; Stephen L Tilley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-04-27       Impact factor: 5.464

10.  Enhanced mast cell activation in mice deficient in the A2b adenosine receptor.

Authors:  Xiaoyang Hua; Martina Kovarova; Kelly D Chason; MyTrang Nguyen; Beverly H Koller; Stephen L Tilley
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

View more
  25 in total

1.  Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system.

Authors:  Dilip K Tosh; Moshe Chinn; Andrei A Ivanov; Athena M Klutz; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

2.  Intracellular adenosine inhibits IgE-dependent degranulation of human skin mast cells.

Authors:  Gregorio Gomez; Vincent Nardone; Sahar Lotfi-Emran; Wei Zhao; Lawrence B Schwartz
Journal:  J Clin Immunol       Date:  2013-11       Impact factor: 8.317

Review 3.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

4.  Dissociation of FK506-binding protein 12.6 kD from ryanodine receptor in bronchial smooth muscle cells in airway hyperresponsiveness in asthma.

Authors:  Ying Du; Jianhong Zhao; Xi Li; Si Jin; Wan-Li Ma; Qing Mu; Shuxiang Xu; Jie Yang; Shanshan Rao; Liping Zhu; Jianbao Xin; Peng-Cheng Cai; Yunchao Su; Hong Ye
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

5.  Gs-coupled adenosine receptors differentially limit antigen-induced mast cell activation.

Authors:  Xiaoyang Hua; Kelly D Chason; Corey Jania; Tatiana Acosta; Catherine Ledent; Stephen L Tilley
Journal:  J Pharmacol Exp Ther       Date:  2012-11-13       Impact factor: 4.030

Review 6.  Investigational A₃ adenosine receptor targeting agents.

Authors:  Balázs Koscsó; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Expert Opin Investig Drugs       Date:  2011-04-02       Impact factor: 6.206

7.  Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.

Authors:  Dilip K Tosh; Francesca Deflorian; Khai Phan; Zhan-Guo Gao; Tina C Wan; Elizabeth Gizewski; John A Auchampach; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2012-05-16       Impact factor: 7.446

Review 8.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

Review 9.  Advances in mechanisms of asthma, allergy, and immunology in 2008.

Authors:  Joshua A Boyce; David Broide; Kenji Matsumoto; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2009-03       Impact factor: 10.793

Review 10.  Myeloid cells in the tumor microenvironment: Role of adenosine.

Authors:  Silvana Morello; Aldo Pinto; Corrado Blandizzi; Luca Antonioli
Journal:  Oncoimmunology       Date:  2015-12-03       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.